Digoxin

Buy now to access the full article, existing subscribers login

Sections available in full article Name, Class of drug, Description, Uses, Administration, Routes of administration, Dosage, Pharmocokinetics, Normal, Physiological, variations, Pathological variations, Precautions, Use with care, Interactions, Adverse reactions, Sources, Publications, Vetstream contributor(s),
Contributors Dr Mark Rishniw BVSc MS DipACVIM
Synonyms Lanoxin, digitalis

Name

  • Digoxin.

Class of drug

  • Cardiac glycoside.

Uses

Action

  • Inhibits Na-K ATPase   →   increased intracellular Ca   →   increased force of myocardial contraction.
  • Acts on SA & AV node   →   increased refractory period and decreased conduction velocity   →   slower heart rate.
  • Slower heart rate + increased force of contraction = increased cardiac output.
  • Normalizes baroreceptor reflexes impaired in heart failure.
  • Increases vagal tone.

Indications

  • Myocardial failure.
  • Supraventricular tachycardia.
  • Congestive heart failure  Congestive heart failure  .

Adverse reactions

Effects of overdosage

  • Discontinue immediately if signs of toxicity occur and measure serum [digoxin].

Other reported reactions

  • Anorexia.
  • Vomiting.
  • Diarrhea.
  • Depression.
  • Seizures.

Arrhythmias

  • Complete or incomplete heart block .
  • Bigeminy.
  • Paroxysmal ventricular or atrial tachycardia with block .
  • Multifocal ventricular premature contractions (VPCs).
  • ALL arrhythmias have been reported with digoxin toxicity  Digoxin toxicity  .

Investigation of adverse reaction

  • Serum [digoxin]: if response inadequate or toxicity observed.
  • Therapeutic serum levels are 1-2 ng/ml.

Treatment

  • Lidocaine  Lidocaine  may be used to control digitalis-associated may be used to control digitalis-associated arrhythmias.

Antidote for overdose

  • 'Digibind' - digoxin-binding antibody fragments can be administered in life-threatening situations. Very expensive.

Sample content only, to unlock the full article login or buy now

Loading...